
NATURE . COM {
}
Title:
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Nature
Description:
Two papers in this issue report the identification of a specific type of colon cancer cell that initiates tumour growth in mice. This lends support to the theory that only a few cells within a tumour, the cancer stem cells, are responsible for tumour formation and maintenance. The finding highlights the importance of finding therapeutics to target cancer stem cells. Colon cancer is one of the best-understood neoplasms from a genetic perspective1,2,3, yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies4,5. What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cells—cancer stem cells—possess such potential6,7. Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133+; the CD133- cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7 × 104 unfractionated tumour cells, whereas there was one CC-IC in 262 CD133+ cells, representing >200-fold enrichment. CC-ICs within the CD133+ population were able to maintain themselves as well as differentiate and re-establish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌆 Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 41,362,249 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$521,200 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $347,485 to $955,583.
Keywords {🔍}
cancer, article, cells, google, scholar, nature, cas, stem, cell, colon, tumour, human, access, dick, research, supplementary, content, cookies, data, information, mice, ads, canada, ontario, privacy, analysis, growth, colorectal, initiating, john, identification, open, molecular, natl, leukemia, clarke, membrane, manuscript, health, jed, institute, author, toronto, permissions, figure, advertising, journal, subscribe, immunodeficient, obrien,
Topics {✒️}
nature portfolio privacy policy colorectal cancer development advertising permissions reprints cells—cancer stem cells—possess canada research chair social media nature immunol nature med health research integrated multi-omics unveils nature 432 nature 414 nature 367 nature nature 445 author information authors p53-independent cross-talk human colon cancer springerlink instant access colon cancer cell immunodeficient nod/scid mice author contributions author correspondence colon cancer cells permissions information colorectal cancer tumorigenesis human colon cancers cancer stem cells competing financial interests personal data /reprints university health network national cancer institute privacy cancer-related death rectal cancer surgery initiating tumour growth permissions cell signaling pathways data protection analysed data natl cancer inst orthotopic xenograft models nod/scid mice explore content subscription content colorectal cancer bulk tumour cells
Schema {🗺️}
WebPage:
mainEntity:
headline:A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
description:Two papers in this issue report the identification of a specific type of colon cancer cell that initiates tumour growth in mice. This lends support to the theory that only a few cells within a tumour, the cancer stem cells, are responsible for tumour formation and maintenance. The finding highlights the importance of finding therapeutics to target cancer stem cells. Colon cancer is one of the best-understood neoplasms from a genetic perspective1,2,3, yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies4,5. What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cellsâcancer stem cellsâpossess such potential6,7. Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133+; the CD133- cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7âÃâ104 unfractionated tumour cells, whereas there was one CC-IC in 262 CD133+ cells, representing >200-fold enrichment. CC-ICs within the CD133+ population were able to maintain themselves as well as differentiate and re-establish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.
datePublished:2006-11-19T00:00:00Z
dateModified:2006-11-19T00:00:00Z
pageStart:106
pageEnd:110
sameAs:https://doi.org/10.1038/nature05372
keywords:
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig2_HTML.jpg
isPartOf:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:445
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Catherine A. OâBrien
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:Aaron Pollett
affiliation:
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
type:Organization
type:Person
name:Steven Gallinger
affiliation:
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:John E. Dick
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
description:Two papers in this issue report the identification of a specific type of colon cancer cell that initiates tumour growth in mice. This lends support to the theory that only a few cells within a tumour, the cancer stem cells, are responsible for tumour formation and maintenance. The finding highlights the importance of finding therapeutics to target cancer stem cells. Colon cancer is one of the best-understood neoplasms from a genetic perspective1,2,3, yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies4,5. What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cellsâcancer stem cellsâpossess such potential6,7. Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133+; the CD133- cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7âÃâ104 unfractionated tumour cells, whereas there was one CC-IC in 262 CD133+ cells, representing >200-fold enrichment. CC-ICs within the CD133+ population were able to maintain themselves as well as differentiate and re-establish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.
datePublished:2006-11-19T00:00:00Z
dateModified:2006-11-19T00:00:00Z
pageStart:106
pageEnd:110
sameAs:https://doi.org/10.1038/nature05372
keywords:
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig2_HTML.jpg
isPartOf:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:445
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Catherine A. OâBrien
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:Aaron Pollett
affiliation:
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
type:Organization
type:Person
name:Steven Gallinger
affiliation:
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:John E. Dick
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:445
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Catherine A. OâBrien
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:Aaron Pollett
affiliation:
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
type:Organization
name:Steven Gallinger
affiliation:
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
type:Organization
name:John E. Dick
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
name:Department of Pathology and Laboratory Medicine,
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(81)
- How much revenue does https://link.springer.com/article/10.1038/nature05372?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle bring in?
- How much does https://doi.org/10.1016%2F0092-8674%2890%2990186-I pull in monthly?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=A%20genetic%20model%20for%20colorectal%20cancer%20tumorigenesis&journal=Cell&doi=10.1016%2F0092-8674%2890%2990186-I&volume=61&pages=759-767&publication_year=1990&author=Fearon%2CER&author=Vogelstein%2CB?
- Profit of https://doi.org/10.1096%2Ffasebj.6.10.1321771
- How much profit is http://scholar.google.com/scholar_lookup?&title=Progressing%20toward%20a%20molecular%20description%20of%20colorectal%20cancer%20development&journal=FASEB%20J.&doi=10.1096%2Ffasebj.6.10.1321771&volume=6&pages=2783-2790&publication_year=1992&author=Fearon%2CER&author=Jones%2CPA making per month?
- How much revenue does https://doi.org/10.1126%2Fscience.1104815 bring in?
- What are the earnings of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2005Sci...307.1904R?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Self-renewal%20and%20cancer%20of%20the%20gut%3A%20two%20sides%20of%20a%20coin&journal=Science&doi=10.1126%2Fscience.1104815&volume=307&pages=1904-1909&publication_year=2005&author=Radtke%2CF&author=Clevers%2CH
- Explore the financials of https://doi.org/10.1093%2Fjnci%2F93.8.583
- Profit of http://scholar.google.com/scholar_lookup?&title=Guidelines%202000%20for%20colon%20and%20rectal%20cancer%20surgery&journal=J.%20Natl%20Cancer%20Inst.&doi=10.1093%2Fjnci%2F93.8.583&volume=93&pages=583-596&publication_year=2001&author=Nelson%2CH
- https://doi.org/10.1093%2Fjnci%2Fdjh275's financial summary
- How profitable is http://scholar.google.com/scholar_lookup?&title=Colon%20cancer%20survival%20rates%20with%20the%20new%20American%20Joint%20Committee%20on%20Cancer%20sixth%20edition%20staging&journal=J.%20Natl%20Cancer%20Inst.&doi=10.1093%2Fjnci%2Fdjh275&volume=96&pages=1420-1425&publication_year=2004&author=O%27Connell%2CJB&author=Maggard%2CMA&author=Ko%2CCY?
- What's the financial outcome of https://doi.org/10.1073%2Fpnas.0830967100?
- How much revenue does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2003PNAS..100.3547D generate?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20stem%20cells%20revealed&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0830967100&volume=100&pages=3547-3549&publication_year=2003&author=Dick%2CJE is on a monthly basis
- How profitable is https://doi.org/10.1016%2Fj.tcb.2005.07.004?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Cancer%20stem%20cells%3A%20lessons%20from%20leukemia&journal=Trends%20Cell%20Biol.&doi=10.1016%2Fj.tcb.2005.07.004&volume=15&pages=494-501&publication_year=2005&author=Wang%2CJC&author=Dick%2CJE?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8899423 earns monthly
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Efficiency%20of%20orthotopic%20xenograft%20models%20for%20human%20colon%20cancers&journal=In%20Vivo&volume=10&pages=463-469&publication_year=1996&author=Pocard%2CM&author=Tsukui%2CH&author=Salmon%2CRJ&author=Dutrillaux%2CB&author=Poupon%2CMF?
- Profit of https://doi.org/10.1158%2F0008-5472.CAN-04-2488
- How much income does http://scholar.google.com/scholar_lookup?&title=Elimination%20of%20hepatic%20metastases%20of%20colon%20cancer%20cells%20via%20p53-independent%20cross-talk%20between%20irinotecan%20and%20Apo2%20ligand%2FTRAIL&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2488&volume=64&pages=9105-9114&publication_year=2004&author=Ravi%2CR have?
- How much does https://doi.org/10.1158%2F0008-5472.CAN-04-2484 make?
- How much income is http://scholar.google.com/scholar_lookup?&title=SKI-606%2C%20a%20Src%2FAbl%20inhibitor%20with%20in%20vivo%20activity%20in%20colon%20tumor%20xenograft%20models&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2484&volume=65&pages=5358-5364&publication_year=2005&author=Golas%2CJM earning monthly?
- What's the financial outcome of https://doi.org/10.1002%2F%28SICI%291097-0339%28199702%2916%3A2%3C132%3A%3AAID-DC7%3E3.0.CO%3B2-J?
- How much does http://scholar.google.com/scholar_lookup?&title=Cytokeratins%2020%20and%207%20in%20the%20differential%20diagnosis%20of%20metastatic%20carcinoma%20in%20cytologic%20specimens&journal=Diagn.%20Cytopathol.&doi=10.1002%2F%28SICI%291097-0339%28199702%2916%3A2%3C132%3A%3AAID-DC7%3E3.0.CO%3B2-J&volume=16&pages=132-136&publication_year=1997&author=Sack%2CMJ&author=Roberts%2CSA pull in monthly?
- See how much https://doi.org/10.1016%2Fj.canlet.2003.10.032 makes per month
- Earnings of http://scholar.google.com/scholar_lookup?&title=Ki-67%20and%20CEA%20expression%20as%20prognostic%20markers%20in%20Dukes%27%20C%20colorectal%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2003.10.032&volume=207&pages=109-115&publication_year=2004&author=Ishida%2CH
- Get to know what's the income of https://doi.org/10.1002%2Fbjs.4447
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Microvessel%20density%2C%20cyclo-oxygenase%202%20expression%2C%20K-ras%20mutation%20and%20p53%20overexpression%20in%20colonic%20cancer&journal=Br.%20J.%20Surg.&doi=10.1002%2Fbjs.4447&volume=91&pages=355-361&publication_year=2004&author=Liang%2CJT have monthly?
- How much does https://doi.org/10.1038%2Fbjc.1963.78 gross monthly?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=The%20efficient%20design%20of%20transplantable%20tumour%20assays&journal=Br.%20J.%20Cancer&doi=10.1038%2Fbjc.1963.78&volume=17&pages=583-595&publication_year=1964&author=Porter%2CEH&author=Berry%2CRJ?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9166828?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Primitive%20human%20hematopoietic%20cells%20are%20enriched%20in%20cord%20blood%20compared%20with%20adult%20bone%20marrow%20or%20mobilized%20peripheral%20blood%20as%20measured%20by%20the%20quantitative%20in%20vivo%20SCID-repopulating%20cell%20assay&journal=Blood&volume=89&pages=3919-3924&publication_year=1997&author=Wang%2CJC&author=Doedens%2CM&author=Dick%2CJE?
- How much revenue does https://doi.org/10.1073%2Fpnas.0530291100 generate?
- How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2003PNAS..100.3983A gross monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Prospective%20identification%20of%20tumorigenic%20breast%20cancer%20cells&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0530291100&volume=100&pages=3983-3988&publication_year=2003&author=Al%20Hajj%2CM&author=Wicha%2CMS&author=Benito-Hernandez%2CA&author=Morrison%2CSJ&author=Clarke%2CMF earns monthly
- Check the income stats for https://doi.org/10.1038%2Fnature03128
- http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2004Natur.432..396S's revenue stream
- Find out how much http://scholar.google.com/scholar_lookup?&title=Identification%20of%20human%20brain%20tumour%20initiating%20cells&journal=Nature&doi=10.1038%2Fnature03128&volume=432&pages=396-401&publication_year=2004&author=Singh%2CSK earns monthly
- What's the income of https://doi.org/10.1038%2F35102167?
- Learn about the earnings of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2001Natur.414..105R
- Revenue of http://scholar.google.com/scholar_lookup?&title=Stem%20cells%2C%20cancer%2C%20and%20cancer%20stem%20cells&journal=Nature&doi=10.1038%2F35102167&volume=414&pages=105-111&publication_year=2001&author=Reya%2CT&author=Morrison%2CSJ&author=Clarke%2CMF&author=Weissman%2CIL
- What's the profit of https://doi.org/10.1242%2Fjcs.02439?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Release%20of%20extracellular%20membrane%20particles%20carrying%20the%20stem%20cell%20marker%20prominin-1%20%28CD133%29%20from%20neural%20progenitors%20and%20other%20epithelial%20cells&journal=J.%20Cell%20Sci.&doi=10.1242%2Fjcs.02439&volume=118&pages=2849-2858&publication_year=2005&author=Marzesco%2CAM
- What's the income of https://doi.org/10.1074%2Fjbc.275.8.5512?
- How profitable is http://scholar.google.com/scholar_lookup?&title=The%20human%20AC133%20hematopoietic%20stem%20cell%20antigen%20is%20also%20expressed%20in%20epithelial%20cells%20and%20targeted%20to%20plasma%20membrane%20protrusions&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.275.8.5512&volume=275&pages=5512-5520&publication_year=2000&author=Corbeil%2CD?
- Profit of https://doi.org/10.1016%2Fj.exphem.2005.05.018
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Dynamic%20changes%20in%20cellular%20and%20microenvironmental%20composition%20can%20be%20controlled%20to%20elicit%20in%20vitro%20human%20hematopoietic%20stem%20cell%20expansion&journal=Exp.%20Hematol.&doi=10.1016%2Fj.exphem.2005.05.018&volume=33&pages=1229-1239&publication_year=2005&author=Madlambayan%2CGJ?
- How much income is https://doi.org/10.1038%2F367645a0 earning monthly?
- What's the income generated by http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1994Natur.367..645L each month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=A%20cell%20initiating%20human%20acute%20myeloid%20leukemia%20after%20transplantation%20into%20SCID%20mice&journal=Nature&doi=10.1038%2F367645a0&volume=367&pages=645-648&publication_year=1994&author=Lapidot%2CT
- How much does https://doi.org/10.1038%2Fni1080 pull in?
- http://scholar.google.com/scholar_lookup?&title=Acute%20myeloid%20leukemia%20originates%20from%20a%20hierarchy%20of%20leukemic%20stem%20cell%20classes%20that%20differ%20in%20self-renewal%20capacity&journal=Nature%20Immunol.&doi=10.1038%2Fni1080&volume=5&pages=738-743&publication_year=2004&author=Hope%2CKJ&author=Jin%2CL&author=Dick%2CJE's revenue stream
- How much does https://doi.org/10.1038%2Fsj.onc.1207947 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Self-renewal%20and%20solid%20tumor%20stem%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1207947&volume=23&pages=7274-7282&publication_year=2004&author=Al%20Hajj%2CM&author=Clarke%2CMF pull in?
- What are the total earnings of https://doi.org/10.1038%2Fnm1379?
- http://scholar.google.com/scholar_lookup?&title=Roots%20and%20stems%3A%20stem%20cells%20in%20cancer&journal=Nature%20Med.&doi=10.1038%2Fnm1379&volume=12&pages=296-300&publication_year=2006&author=Polyak%2CK&author=Hahn%2CWC income
- What is the earnings of https://doi.org/10.1016%2Fj.gde.2003.11.007?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20implications%20of%20cancer%20stem%20cells&journal=Curr.%20Opin.%20Genet.%20Dev.&doi=10.1016%2Fj.gde.2003.11.007&volume=14&pages=43-47&publication_year=2004&author=Al%20Hajj%2CM&author=Becker%2CMW&author=Wicha%2CM&author=Weissman%2CI&author=Clarke%2CMF?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1038/nature05372?format=refman&flavour=references produce monthly?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Catherine%20A.%20O%E2%80%99Brien?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Catherine%20A.%20O%E2%80%99Brien%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aaron%20Pollett?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aaron%20Pollett%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Steven%20Gallinger?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Steven%20Gallinger%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=John%20E.%20Dick earns monthly
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22John%20E.%20Dick%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- How much does https://static-content.springer.com/esm/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_BFnature05372_MOESM1_ESM.pdf generate monthly?
- How much does https://static-content.springer.com/esm/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_BFnature05372_MOESM2_ESM.doc rake in every month?
- How much does https://s100.copyright.com/AppDispatchServlet?title=A%20human%20colon%20cancer%20cell%20capable%20of%20initiating%20tumour%20growth%20in%20immunodeficient%20mice&author=Catherine%20A.%20O%E2%80%99Brien%20et%20al&contentID=10.1038%2Fnature05372©right=Springer%20Nature%20Limited&publication=0028-0836&publicationDate=2006-11-19&publisherName=SpringerNature&orderBeanReset=true gross monthly?
- How much income does https://citation-needed.springer.com/v2/references/10.1038/nature05372?format=refman&flavour=citation have?
- Check the income stats for https://doi.org/10.1186/s11658-024-00554-0
- How much does https://doi.org/10.1038/s43018-024-00723-2 pull in monthly?
- https://doi.org/10.1038/s41467-024-47227-2 income
- Profit of https://doi.org/10.1007/s10555-023-10149-4
- What's the income generated by https://doi.org/10.1186/s13046-023-02931-7 each month?
- How much does https://www.protocols.io/ pull in monthly?
- What is the monthly revenue of https://www.natureindex.com/?
- Learn about the earnings of http://www.naturechina.com
- How profitable is https://www.natureasia.com/ja-jp?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref